Edgar Filing: Meggs Jason M.

Ownership Submission

FORM 3

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934, Section 17(a) of the Public Utility Holding Company Act of 1935 or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:

3235-0104

Expires:

January 31, 2005

Estimated average burden hours per response...

0.5

(Print or Type Responses)

1. Name and Address of Reporting Person ^*

Â Meggs Jason M.

2. Date of Event Requiring Statement (Month/Day/Year)
02/21/2018

3. Issuer Name and Ticker or Trading Symbol
Syneos Health, Inc. [SYNH]

(Last)

(First)

(Middle)

C/O SYNEOS HEALTH, INC.,Â 3201 BEECHLEAF COURT, SUITE 600

4. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

_____ Director	_____ 10% Owner
__X__ Officer (give title below)	_____ Other (specify below)
EVP and Interim CFO

5. If Amendment, Date Original Filed(Month/Day/Year)

(Street)

RALEIGH,Â NCÂ 27604

6. Individual or Joint/Group Filing(Check Applicable Line)
_X_ Form filed by One Reporting Person
___ Form filed by More than One Reporting Person

(City)

(State)

(Zip)

Table I - Non-Derivative Securities Beneficially Owned

1.Title of Security (Instr. 4)	2. Amount of Securities Beneficially Owned (Instr. 4)	3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	4. Nature of Indirect Beneficial Ownership (Instr. 5)
Class A Common Stock	34,797 ⁽¹⁾	D	Â

Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.			SEC 1473 (7-02)
	Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB control number.

Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)

1. Title of Derivative Security (Instr. 4)	2. Date Exercisable and Expiration Date (Month/Day/Year)		3. Title and Amount of Securities Underlying Derivative Security (Instr. 4)		4. Conversion or Exercise Price of Derivative Security	5. Ownership Form of Derivative Security: Direct (D) or Indirect (I) (Instr. 5)	6. Nature of Indirect Beneficial Ownership (Instr. 5)
1. Title of Derivative Security (Instr. 4)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares	4. Conversion or Exercise Price of Derivative Security		6. Nature of Indirect Beneficial Ownership (Instr. 5)
Stock Option (Right to Buy Class A Common Stock)	Â ⁽²⁾	07/29/2025	Class A Common Stock	2,108	$ 43.16	D	Â
Stock Option (Right to Buy Class A Common Stock)	Â ⁽³⁾	01/19/2026	Class A Common Stock	2,600	$ 42.88	D	Â
Stock Option (Right to Buy Class A Common Stock)	Â ⁽⁴⁾	11/01/2026	Class A Common Stock	620	$ 46	D	Â

Reporting Owners

Reporting Owner Name / Address	Relationships
Reporting Owner Name / Address	Director	10% Owner	Officer	Other
Meggs Jason M. C/O SYNEOS HEALTH, INC. 3201 BEECHLEAF COURT, SUITE 600 RALEIGH,Â NCÂ 27604	Â	Â	Â EVP and Interim CFO	Â

Signatures

/s/ Donald R. Reynolds, Attorney-in-Fact		03/02/2018
^**Signature of Reporting Person		Date

Explanation of Responses:

*	If the form is filed by more than one reporting person, see Instruction 5(b)(v).
**	Intentional misstatements or omissions of facts constitute Federal Criminal Violations. See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
(1)	Includes (i) 1,054 shares of restricted stock units ("RSUs") that vest 527 shares on each of July 29, 2018 and July 29, 2019; (ii) 866 shares of RSUs that vest 433 shares on each of January 19, 2019 and January 19, 2020; (iii) 232 shares of RSUs that vest 78 shares on November 1, 2018 and 77 shares on each of November 1, 2019 and November 2, 2020; (iv) 2,555 shares of RSUs that vest 1,278 shares on January 27, 2019 and 1,277 shares on January 27, 2020; and (v) 26,490 shares of RSUs that vest 8,830 shares on each of February 15, 2019, 2020 and 2021, subject to continued employment.
(2)	The shares subject to this option vest in four equal annual installments beginning on July 29, 2016 subject to continued employment.
(3)	The shares subject to this option vest in four equal annual installments beginning on January 19, 2017 subject to continue employment.
(4)	The shares subject to this option vest in four equal annual installments beginning on November 1, 2017 subject to continued employment.

Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, See Instruction 6 for procedure.

Potential persons who are to respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB number.